Shin Kong Life Insurance Issuer Summary

Report date: 2026-05-15
Issuer: Shin Kong Life Insurance Co., Ltd.
Ticker: SHIKON
Sector: Taiwan life insurance
Primary credit focus: issuer credit, insurer financial strength, integration with Taishin Life, regulatory capital, FX/ALM, and ranking differences for USD Tier 2 subordinated debt

1. Business Snapshot and Recent Developments

Shin Kong Life Insurance Co., Ltd.（新光人壽, hereafter Shin Kong Life）is a major Taiwanese life insurance company. The starting point for credit analysis is to view the company not as a bank or a general corporate, but as a life insurance issuer with long-duration insurance contract liabilities and large domestic and overseas investment assets backing those liabilities. Premium generation capability, distribution network, and persistency support the franchise, but they do not by themselves determine credit quality. The analysis must read together the guaranteed rates embedded in insurance liabilities, surrender behaviour, medical and accident claims, foreign-currency assets, FX hedging, regulatory capital, IFRS 17 / Taiwan’s new capital regime, and the ranking of subordinated capital securities.

This report first separates three scopes that intersect under the same Shin Kong Life name. The first is the former Shin Kong Life, established in 1963, which was the core life insurance company under the former Shin Kong Financial Holding until Shin Kong Financial Holding merged with Taishin Financial Holding on 24 July 2025. The second is the former Shin Kong Life segment incorporated into the consolidated group of TS Financial Holding Co., Ltd.（hereafter TS Holdings）from 24 July 2025 onward. The third is the post-merger life insurance company formed on 1 January 2026 through the merger of Taishin Life and Shin Kong Life, with Taishin Life as the surviving legal entity while using the Shin Kong Life name. The first caution in this report is not to mechanically place the former company’s 2024 financials, the 2025 TS Holdings consolidated segment, and the post-merger company from 2026 onward side by side as if they were the same reporting perimeter.

In business profile terms, Shin Kong Life was a large player in Taiwan’s life insurance market. According to the June 2025 USD Tier 2 Offering Circular, its 2024 market share by total premiums was 7.8%, ranking fourth among Taiwanese life insurers. The same document states that, as of end-2024, the company had more than 7,300 sales agents, 3.93 million insured persons, and 8.99 million in-force policies, with a 13-month persistency ratio of 96.7% and a 25-month persistency ratio of 93.7%.

The largest recent change is the merger of Taishin Financial and Shin Kong Financial, and the merger of Taishin Life and Shin Kong Life. TS Holdings’ 4Q25 Quick Fact explains that the two holding companies merged on 24 July 2025, creating Taiwan’s fourth-largest financial holding company with assets of more than NT$8 trillion. The life insurance subsidiaries were merged on 1 January 2026. As a result, credit analysis of Shin Kong Life is both a standalone insurer analysis and an analysis of a core life insurance platform within a large financial group immediately after integration.

The merger brings both credit support and uncertainty. The support comes from Taishin’s banking, securities, and asset management platforms, Shin Kong Life’s life insurance franchise, the complementarity of bancassurance and agency channels, and the group’s potential capacity to raise capital. TS Holdings’ 4Q25 presentation states that the combined life insurance subsidiaries generated 2025 net income after tax of NT$7.7bn, of which Shin Kong Life contributed NT$5.7bn from 24 July to 31 December 2025. It also shows that Shin Kong Life’s 2025 new business CSM rose 69% year on year to NT$64.9bn, indicating that the former Shin Kong Life was attempting to shift toward a product mix more focused on future profitability and capital efficiency.

At the same time, the merger does not immediately eliminate credit risk. On 14 November 2025, Fitch Ratings maintained Shin Kong Life’s Insurer Financial Strength Rating at BBB and its Long-Term Issuer Default Rating at BBB-, while maintaining the Rating Watch Evolving. This report confirmed the release through Reuters / TradingView republication rather than the official Fitch page, and therefore uses it only to confirm the rating levels and key analytical points. Fitch focused on uncertainty over balance sheet strength after the January 2026 merger with Taishin Life, including the review of assets closer to fair value, capital sensitivity to Taiwan dollar appreciation, and changes in presentation associated with IFRS 17 adoption. Fitch’s view is that the merger may improve the company profile, but the final state of capital and FX exposure is still not clear. This is consistent with the central analytical point of this report.

On capital, it is also necessary to distinguish the former Shin Kong Life from the post-merger company. TS Holdings’ 2025 consolidated financial statements state that, for the former Shin Kong Life, temporary measures allowed its capital adequacy ratio to exceed 200% and its net worth ratio to exceed 3% in 1H25, thereby meeting statutory requirements. In 2H25, however, due to continued Taiwan dollar appreciation under the average FX rate mechanism, the capital adequacy ratio at end-2025 did not meet the statutory requirement, while the net worth ratio remained above 3%. In contrast, TS Holdings’ 4Q25 presentation shows the RBC ratio for Taishin Life -> Shin Kong Life at 421% at end-December 2025, and the new-generation solvency regime（TIS）at above 125% from 1 January 2026. This is an indicator for the legal surviving entity or the immediately pre-/post-integration platform, and is not the same perimeter as the former Shin Kong Life’s non-compliance at end-2025. TIS above 125% indicates that the ratio exceeded the minimum level, but the stress buffer and the extent to which risks inherited from the former Shin Kong Life remain are still unclear. Investors need to confirm in the 2026 post-merger financials whether the former Shin Kong Life’s weakness has been substantively resolved after integration.

In June 2025, Shin Kong Life Singapore Pte. Ltd. issued USD400mn of 6.95% Tier 2 subordinated dated capital bonds due 2035, guaranteed by Shin Kong Life on a subordinated basis. This demonstrates access to international capital markets and capital reinforcement, but the guarantee is not a senior guarantee. The Offering Circular defines both the issuer’s obligations and Shin Kong Life’s guarantee as direct, unconditional, unsecured, and subordinated obligations. Therefore, the subordination as Tier 2 capital, regulatory capital characteristics, redemption restrictions, and the possibility of a change in guarantor due to a merger event must be analysed separately.

In one sentence, the current profile is that Shin Kong Life is a life insurance credit with a large incumbent franchise in Taiwan’s life insurance market, but whose credit assessment depends on how far the legacy capital vulnerability and foreign-currency/ALM risk from the former company can be improved after integration into TS Holdings. The merger is clearly a potential credit positive, but at this stage it should be treated as a transition process rather than completed improvement.

2. Industry Position and Franchise Strength

Taiwan’s life insurance market includes long-term savings-type insurance, protection-type insurance, medical and accident insurance, foreign-currency insurance, investment-linked products, and annuity products. For credit analysis, the key question is not simply whether new business premiums grow, but what risks those premiums carry. Foreign-currency savings products may improve ALM with foreign-currency assets, but they are exposed to policyholder explanation, FX risk, hedging cost, and regulatory effects. Protection-type products may contribute to future profits and CSM, but their profitability depends on medical inflation, claims incidence, rate revisions, and reinsurance. Investment-linked products can shift part of market risk to policyholders, but they involve sales quality, fees, complaints, surrenders, and brand risk.

The former Shin Kong Life’s strengths lie in its long operating history in the Taiwanese market, brand, agency network, and policyholder base. Its 2024 total premiums of NT$190.4bn, FYP of NT$64.2bn, and total assets of NT$3,699.0bn show that the company was not a marginal issuer in Taiwan’s life insurance market, but a large incumbent franchise. The Offering Circular explains that the company ranked fourth in Taiwan by total premiums and third by FYP（excluding investment-linked products）in 2024. TS Holdings’ 4Q25 presentation also shows Shin Kong Life’s 2025 total premiums at NT$187.5bn, FYP at NT$59.3bn, first-year premium equivalent at NT$24.3bn, and new business CSM at NT$64.9bn.

However, focusing only on premium volume would be misleading. FYP decreased by 8% in 2025 from 2024, while first-year premium equivalent increased by 7% and new business CSM increased by 69%. These figures should be treated as Shin Kong Life management indicators in TS Holdings’ 4Q25 presentation and distinguished from audited full-year standalone financial statements of the former Shin Kong Life. CSM/FYP rose from 61.4% in 2024 to 109.5% in 2025. This suggests a possible change not merely in premium volume, but in product mix and the quality of future profits. From a credit perspective, the decline in FYP should not be immediately read as deterioration. It must be assessed together with growth in protection, health, and group insurance, the lower share of investment-linked products, the foreign-currency insurance ratio, first-year premium equivalent, CSM, and required capital.

Distribution channels are also important. In 2024, Shin Kong Life relied mainly on the agency channel, with sales personnel accounting for most FYP. Taishin Life, by contrast, had strength in bancassurance. The Offering Circular explains that the former Shin Kong Life depended on agents, while Taishin Life mainly used bancassurance; therefore, after the merger, the share of bancassurance is expected to rise and the agency channel share to decline. From a credit perspective, this broadens channel diversification and cross-selling opportunities, but also creates execution risk in distribution costs, commissions, product selection, customer protection, and channel integration.

Shin Kong Life’s positioning within the TS Holdings group also changes its franchise. TS Holdings is an integrated financial group comprising Taishin Bank, Shin Kong Bank, Taishin Securities, MasterLink Securities, investment trust, investment advisory, leasing, and asset management businesses. The 4Q25 Quick Fact explains that the group has more than 200 bank branches, more than 50 securities branches, and more than 300 insurance service locations. The ability to sell insurance products within a group customer base, rather than as a standalone insurer, may support the business platform over the long term.

At the same time, being a core subsidiary within a financial holding company is separate from an explicit guarantee on a specific debt instrument. The fact that TS Holdings is strong or large does not make Shin Kong Life’s Tier 2 bonds senior guaranteed obligations. Creditors of the life insurer must check the ranking of capital securities subordinated to policyholders, regulatory approval, capital adequacy, and priority in intra-group capital allocation.

In peer comparison, Shin Kong Life is one of Taiwan’s leading life insurers, but the 2023 capital shortfall and the former company’s end-2025 capital non-compliance are heavy constraints. From 2026 onward, as an integrated platform under TS Holdings, it will be linked to banking, securities, and asset management. It is therefore more appropriate to view the credit as a large former Shin Kong Life with capital vulnerability being reorganised within a broader financial group.

3. Segment Assessment

For a life insurance company, segment assessment cannot simply list revenue and operating profit by division as with a general corporate. In Shin Kong Life’s case, product type, distribution channel, insurance liabilities, investment assets, FX and hedging, reinsurance, and regulatory capital together determine credit quality. Public information does not provide sufficient detail on product-level margins, claims ratios, surrender rates, guaranteed rates, or reinsurance terms. This report therefore organises the credit interpretation based on confirmed premium composition, CSM, investment composition, and rating agency comments.

By product, traditional insurance remains the core. TS Holdings’ 4Q25 presentation shows that, of Shin Kong Life’s 2025 total premiums of NT$187.5bn, traditional products accounted for NT$131.5bn, investment-linked products NT$6.4bn, interest-sensitive annuities NT$0.1bn, and accident, health, and group insurance NT$49.6bn. For FYP, of the 2025 total of NT$59.3bn, traditional products accounted for NT$47.0bn, investment-linked products NT$4.1bn, interest-sensitive annuities NT$0.1bn, and accident, health, and group insurance NT$8.2bn. Traditional insurance creates a premium base and long-duration contracts, but consumes capital through guaranteed rates, reinvestment yields, surrenders, insurance liability valuation, and ALM.

Growth in protection, health, and group insurance is a point to note. In 2025 FYP, accident, health, and group insurance increased from NT$5.8bn in 2024 to NT$8.2bn, while new business CSM increased from NT$38.5bn to NT$64.9bn. Expansion in protection-type products may reduce dependence on interest guarantees and improve capital efficiency, but it cannot be judged as an unambiguously better product mix unless claims incidence, medical costs, rate revision ability, reinsurance, and sales quality are confirmed.

Foreign-currency insurance is also a central issue. The foreign-currency insurance ratio in 2025 was shown at 67.6% on an FYP basis, slightly lower than 70.6% in 2024 but still high. Foreign-currency insurance may reduce currency mismatch with foreign-currency investment assets, but the analysis must confirm whether policyholders understand FX risk, whether sales quality is sufficient, whether regulation may become stricter, and whether the duration of foreign-currency liabilities matches the duration of foreign-currency assets. Fitch’s focus on Taiwan dollar appreciation and the capital sensitivity of USD assets at Shin Kong Life reflects the foreign-currency asset / domestic liability structure specific to Taiwanese life insurers.

Investment-linked insurance declined to NT$4.1bn of 2025 FYP from NT$6.4bn in 2024. Investment-linked products can shift part of market risk to policyholders, but they involve sales commissions, customer protection, surrenders, and brand risk. The increase in CSM/FYP in 2025 may indicate a shift toward value, but credit improvement cannot be concluded without confirming product-level CSM, expenses, and claims.

The investment asset composition is even more important than the product segment. TS Holdings’ 4Q25 presentation shows Shin Kong Life’s 2025 total investments at NT$3,485.0bn, of which 66.4% was overseas fixed-income assets, 12.2% domestic fixed-income assets, 6.8% domestic equities, 2.9% overseas equities, 3.0% policy loans, 1.4% secured loans, 6.9% real estate, and 2.3% cash. In the regional breakdown of overseas fixed-income investments, North America accounted for 42.4%, Europe 23.2%, and Asia Pacific and others 34.4%. This shows that the company’s investment operation depends heavily not only on Taiwanese local assets, but also on the US dollar, overseas credit, global rates, and hedging costs.

Investment performance weakened in 2025. The post-hedging investment return was 2.57%, down from 3.71% in 2024, and the pre-hedging recurring yield of 3.37% was also below the liability cost of 3.71%. This constrains spread income and capital.

The overall segment conclusion is that Shin Kong Life should be analysed not merely as a company that collects premiums, but as an issuer whose credit depends on which insurance liabilities are backed by assets of which currency, duration, rating, and liquidity. The 2025 increase in new business CSM is a positive factor, but foreign-currency insurance, overseas fixed-income assets, hedging cost, liability cost, and regulatory capital non-compliance coexist. Whether product improvement translates into credit improvement must be confirmed from 2026 onward in the post-merger financials through CSM, TIS/RBC, hedging costs, ALM, surrenders, claims, and investment gains/losses.

4. Financial Profile and Analysis

Shin Kong Life’s financial profile combines a large life insurance franchise from the former company period with earnings and capital instability. The company recorded losses in 2022 and 2023 and returned to profit in 2024, but the former Shin Kong Life’s capital adequacy ratio at end-2025 did not meet the statutory requirement. TS Holdings’ 2025 consolidated disclosures show profit contribution and product value improvement at the group level after integration, but they do not fully show the former company’s standalone full-year earnings power or the post-merger company’s capital position from 2026 onward. Therefore, the financial analysis separately reads confirmed historical data for the former company, TS Holdings’ 2025 segment information, and post-merger capital indicators.

Looking at the former Shin Kong Life in 2022-2024, premiums and investment assets were large, but earnings were affected by markets, FX, and capital policy. Total premiums in 2024 were NT$190.4bn, recovering from NT$167.5bn in 2023. FYP was NT$64.2bn in 2024, a sharp increase from NT$38.9bn in 2023. Total assets were NT$3,699.0bn at end-2024, up from NT$3,587.5bn at end-2023. Investment income was NT$130.3bn in 2024, total investments were NT$3,394.3bn, and the investment yield was 3.71%. Net income after tax in 2024 was NT$10.2bn, returning to profit after a loss of NT$4.9bn in 2022 and a loss of NT$17.2bn in 2023. The figures in this paragraph are for the former Shin Kong Life on a company basis for 2022-2024 and differ from the perimeter after integration into TS Holdings.

However, the return to profit in 2024 should not be viewed as resolving the capital issue by itself. The Offering Circular explains that the 2023 capital adequacy ratio did not meet the statutory capital adequacy level, and although the net worth ratio was above 3%, the company was classified as capital deficient. Subsequently, in 2024, the capital adequacy ratio returned to above 200% and the net worth ratio to above 3% at mid-year and year-end, supported by equity market recovery, realised equity gains, the effect of the foreign currency price fluctuation reserve mechanism, capital injection, and issuance of domestic subordinated debt. In other words, the 2024 improvement depended not only on organic earnings accumulation, but also on the market environment and capital reinforcement.

The main metrics are summarised below. The 2022-2024 figures are based on former Shin Kong Life company disclosures / the Offering Circular, while the 2025 figures are based on TS Holdings presentation materials / consolidated financial statements, and therefore have perimeter differences.

In TS Holdings’ 2025 consolidated financial statements, the Shin Kong Life Insurance consolidated segment had total assets of NT$3,666.3bn at end-2025, net revenue and gains of NT$12.1bn, and a pre-tax loss of NT$12.5bn. At the same time, TS Holdings’ 4Q25 presentation also states that Shin Kong Life contributed net income after tax of NT$5.7bn from 24 July to 31 December 2025. Because of differences in perimeter, acquisition-date fair value assessment, reserves, PPA, and period covered, these should not be mechanically compared as the former Shin Kong Life’s full-year 2025 operating capacity.

Capital is more important. The 2025 consolidated financial statements state that, for the former Shin Kong Life, temporary measures such as the average FX rate mechanism and adjustments to reserve calculation bases allowed the capital adequacy ratio to exceed 200% and the net worth ratio to exceed 3% in 1H25, meeting statutory requirements. However, in 2H25, due to the continuation of the semi-annual average FX rate mechanism and Taiwan dollar appreciation in the average exchange rate, the capital adequacy ratio at end-2025 did not meet the statutory requirement, while the net worth ratio remained above 3%. The exact RBC ratio for the former Shin Kong Life at end-2025 could not be confirmed in the English consolidated financial statements. Therefore, this report treats “non-compliance” and “net worth ratio above 3%” as confirmed facts, while leaving the exact ratio level as an unconfirmed item.

TS Holdings’ 4Q25 presentation shows the RBC ratio for the post-merger life insurance platform labelled Taishin Life -> Shin Kong Life at 353% in December 2023, 323% in June 2024, 349% in December 2024, 458% in June 2025, and 421% in December 2025. It also shows the new-generation solvency regime（TIS）from 1 January 2026 at above 125%. This indicates the capital base of the legal surviving Taishin Life side or the immediately pre-/post-integration platform, and does not contradict the former Shin Kong Life’s end-2025 non-compliance. Rather, it is an entry point for confirming how capital is remeasured after integration. TIS above 125% indicates a level above the minimum, but the thickness of the buffer, sensitivity to FX and interest-rate stress, residual losses inherited from the former Shin Kong Life, and the need for future capital injections are still not sufficiently visible.

On investment, 2025 profitability was weak. The post-hedging investment return in 2025 was 2.57%, down from 3.71% in 2024. The pre-hedging recurring yield was 3.37%, while the liability cost was 3.71%, meaning the liability cost exceeded the pre-hedging recurring yield. In addition, the foreign currency price fluctuation reserve increased from NT$27.3bn in 2022, NT$13.2bn in 2023, and NT$45.1bn in 2024 to NT$99.6bn in 2025, and was shown at NT$56.0bn on 1 January 2026. The 2025 hedging cost was 2.17%, up from 1.47% in 2024. As a life insurer with large foreign-currency assets, FX and hedging are directly linked to earnings and capital.

Overall, Shin Kong Life’s financial profile is large in terms of business scale and premium base, but has clear constraints in standalone capital and investment income stability. The post-merger TS Holdings platform may mitigate these constraints, but the fact that the former Shin Kong Life’s capital adequacy ratio did not meet the statutory requirement at end-2025 is the most important fact to weigh in initial coverage.

5. Structural Considerations for Bondholders

For bondholders, Shin Kong Life has two structural issues. The first is the relationship among the parent company, the insurance subsidiaries, and the banking subsidiaries under TS Holdings. The second is the relationship between the issuing vehicle, Shin Kong Life Singapore Pte. Ltd., and the subordinated guarantee from Shin Kong Life itself in the USD Tier 2. Core status within a financial holding company may raise the probability of support, but it does not mean an explicit guarantee or senior ranking for a specific obligation.

The USD400mn 6.95% Tier 2 subordinated dated capital bonds due 2035 issued on 26 June 2025 have Shin Kong Life Singapore Pte. Ltd. as the issuer and Shin Kong Life Insurance Co., Ltd. as the guarantor. According to the Offering Circular, the bonds are direct, unconditional, unsecured, and subordinated obligations of the issuer, and the guarantee is also a direct, unconditional, unsecured, and subordinated obligation of Shin Kong Life. In liquidation, claims under the bonds and the guarantee are subordinated to Senior Creditors, rank pari passu with Parity Obligations, and rank senior to Junior Obligations.

Therefore, what matters is not simply that there is a guarantee, but that the guarantee is subordinated. Because the bonds rank below policyholders, senior creditors, and other senior-ranking obligations, Tier 2 cannot be assessed only by the insurer’s financial strength or the size of the parent group. The Offering Circular also provides for early redemption due to tax events, tax deductibility events, minimal outstanding amount events, regulatory capital events, and other triggers, but for regulatory capital securities, regulatory approval and capital condition may constrain redemption.

A Merger Event also remains an unconfirmed risk. The Offering Circular allows a Substituted Obligor to replace the guarantor if a Merger Event occurs. This report has not confirmed the Trust Deed text, the execution status of the Substituted Obligor after the merger, or completion of the practical guarantor change. For domestic subordinated debt, it has been confirmed that the former Shin Kong Life issued NT$13.0bn in 2023 and a total of NT$8.3bn in 2024, but the individual terms, security, redemption, and post-merger succession remain unconfirmed.

The structural interpretation should separate the insurer financial strength of the post-merger Shin Kong Life, potential capital support from TS Holdings, and the ranking and terms of the individual bonds. For investment in the USD Tier 2, the third point is particularly important.

6. Capital Structure, Liquidity and Funding

When analysing Shin Kong Life’s capital structure and funding, it is necessary to consider regulatory capital as an insurer, the liquidity of investment assets, foreign-currency assets and liabilities, subordinated capital securities, and the possibility of parent support together. Comparing only short-term borrowings and cash, as for a general corporate, would miss the centre of credit risk. The main liabilities of an insurer are insurance contract liabilities, on top of which sit capital securities, domestic subordinated debt, issuing-vehicle debt, and intra-group capital movements.

The former Shin Kong Life experienced capital deficiency in 2023. According to the Offering Circular, the capital adequacy ratio at mid-year and year-end 2023 did not meet the statutory level, and although the net worth ratio remained above 3%, the company was classified as capital deficient. This shows that the company’s capital is affected not merely by earnings shortfalls, but also by markets, interest rates, FX, and regulatory calculations.

In 2024, capital was reinforced through a private placement capital increase and domestic subordinated debt issuance. As a result, the capital adequacy ratio exceeded 200% and the net worth ratio exceeded 3% at mid-year and year-end 2024. Capital market access and parent support can be confirmed, but it is difficult to say that sufficient organic capital generation was achieved without reinforcement.

In 2025, the company issued USD400mn of Tier 2. The coupon was 6.95%, the maturity was 2035, and S&P’s expected rating was BBB. The ability to raise capital from international investors is supportive, but the fact that the former Shin Kong Life needed capital reinforcement is itself a constraint.

For the end-2025 capital assessment, attention is required to the perimeter difference between the former Shin Kong Life and the post-merger company. TS Holdings’ 2025 consolidated financial statements state that the former Shin Kong Life’s end-2025 capital adequacy ratio did not meet the statutory requirement. In contrast, TS Holdings’ 4Q25 presentation shows the 2025-end RBC ratio for Taishin Life -> Shin Kong Life at 421%, and the TIS ratio on 1 January 2026 at above 125%. This is a presentation of the capital of the legal surviving entity or the initial integration platform, and does not prove that the former Shin Kong Life’s weak capital position was fully resolved. For investors, the most important items will be post-merger Shin Kong Life’s TIS, capital buffer, sensitivities, and parent capital commitment from 1Q26 onward.

The sequence of capital, funding, and ratings is summarised below. Here again, the perimeter difference between the former Shin Kong Life and the post-merger platform should not be confused.

Liquidity cannot be sufficiently quantified from public information alone. As a life insurer, the company has large investment assets. Of total investments of NT$3,485.0bn in 2025, overseas fixed income accounted for 66.4%, domestic fixed income 12.2%, domestic equities 6.8%, real estate 6.9%, and cash 2.3%. Fixed-income assets may be a source of liquidity in normal conditions, but if interest-rate increases, spread widening, FX hedge collateral needs, and rising surrenders occur together, asset sales with mark-to-market losses or capital pressure could result. Real estate is less liquid, and the quality of policy loans and secured loans and the value of collateral need confirmation.

FX hedging and the foreign currency price fluctuation reserve are important buffers for capital and liquidity. The 2025 total foreign-currency assets were NT$2,401.4bn, broken down into 34.7% hedged, 34.0% unhedged, 30.2% foreign-currency insurance, and 1.1% equities and funds. Foreign-currency insurance provides some natural hedge, but the unhedged portion is also large. The foreign currency price fluctuation reserve increased to NT$99.6bn in 2025, but was shown at NT$56.0bn on 1 January 2026, making simple comparison difficult due to integration, accounting standards, and regime transition effects.

In the overall assessment of capital and liquidity, Shin Kong Life has capital-raising access under TS Holdings, but the former company’s capital vulnerability is clear. From a policyholder protection perspective, TIS/RBC, the net worth ratio, foreign-currency reserves, hedging, ALM, and investment asset liquidity are important. For subordinated debt investors, interest payment and redemption restrictions and non-call risk are also important.

7. Rating Agency View

Ratings are useful for organising Shin Kong Life’s credit quality, but for an insurer it is important not to confuse rating types and scales. Insurer Financial Strength is an assessment close to the ability to pay insurance policy obligations, and differs from an Issuer Default Rating or long-term issuer rating. Taiwan national scale ratings indicate relative position within the domestic market and should not be mechanically compared with international rating symbols. Tier 2 ratings reflect not only issuer credit quality but also subordination, capital characteristics, loss absorption, and regulatory constraints.

On 14 November 2025, Fitch maintained Shin Kong Life’s IFS at BBB, Long-Term IDR at BBB-, National Long-Term Rating at A(twn), and National Long-Term IFS at A+(twn), while maintaining the Rating Watch Evolving. The Fitch release text could not be obtained directly from the official site and was confirmed through TradingView / Reuters republication. Therefore, this report uses it only to confirm the rating levels and key issues. Fitch’s central points are uncertainty over the final state of capital and earnings after fair value assessment accompanying the January 2026 merger with Taishin Life, potential capital pressure from Taiwan dollar appreciation, and the simultaneous occurrence of IFRS 17 transition and integration.

Fitch stated that the former Shin Kong Life’s Fitch Prism score improved from the upper end of Strong at end-2024 to the lower end of Very Strong at end-3Q25. However, this improvement also reflected the inclusion of the foreign currency valuation reserve in available capital under the foreign currency valuation reserve mechanism introduced in December 2024. Fitch also explained that the RBC ratio declined from 221% at end-2024 to 205% at end-1H25. Therefore, Fitch’s assessment should be read not as a simple view that capital is structurally thick, but as one strongly dependent on regulatory reserves, FX, and post-merger fair value assessment.

For S&P, TS Holdings’ 4Q25 Quick Fact shows Shin Kong Life’s S&P rating at BBB+, Outlook Negative. In addition, Cbonds’ public page states that S&P assigned Shin Kong Life a BBB+ foreign-currency long-term credit rating with a Negative outlook on 13 June 2025. However, the detailed S&P report text has not been obtained in this report, so the downgrade and upgrade triggers used by S&P are not determined here. The use is limited to confirmation of the rating level, and detailed capital and integration assessment remains unconfirmed.

For Taiwan Ratings, the public profile shows Shin Kong Life’s long-term rating at twAA-, Outlook Negative, and includes a release stating that Shin Kong Life’s twAA- rating was withdrawn after its merger with Taishin Life on 31 December 2025. The same profile shows an Issue Rating of twA+ for domestic subordinated debt. National scale ratings indicate relative position within the Taiwanese market and do not have the same meaning as S&P/Fitch international ratings for global investors.

Ratings for the overall TS Holdings group are also relevant. The 4Q25 Quick Fact shows TS Holdings at Fitch BBB / Rating Watch Negative and S&P BBB / Negative, and Taishin Bank at Fitch BBB+ / Stable and S&P BBB+ / Developing. Group ratings reflect the credit quality and integration risk of the financial holding company, including banking, securities, and insurance, rather than Shin Kong Life on a standalone basis. Shin Kong Life is a core life insurance business within the group, but its capital, FX, and insurance liability uncertainties are larger than those of the banking subsidiaries.

The rating agency views and this report’s analysis are broadly aligned. The business platform and post-merger company profile are supports, while the former company’s capital vulnerability, Taiwan dollar appreciation, foreign-currency assets, IFRS 17/TIS transition, fair value assessment, and integration execution risk are constraints. In summary, Fitch rates the IFS BBB, IDR BBB-, National A(twn) / IFS A+(twn), Rating Watch Evolving, as confirmed through Reuters republication. S&P is confirmed only at BBB+ / Negative through TS Holdings materials and Cbonds, and the detailed report text has not been obtained. Taiwan Ratings shows twAA- / Negative and domestic subordinated debt at twA+ on a national scale, with a rating withdrawal history after integration on 31 December 2025. The USD Tier 2 had an expected S&P rating of BBB at issuance, reflecting subordination and capital characteristics rather than senior credit.

8. Credit Positioning

Shin Kong Life’s credit positioning is best framed as a transition-period credit: it has a large incumbent franchise in Taiwan’s life insurance market, but capital and FX/ALM constraints are significant, and improvement after integration into TS Holdings still needs to be verified. As with other leading Taiwanese life insurers, the analysis should focus on overseas fixed-income assets, foreign-currency insurance, hedging, insurance liabilities, and IFRS 17/TIS transition. However, because the former company’s capital deficiency and end-2025 capital adequacy non-compliance are clear, the view of credit headroom should be conservative.

Looking only at the business platform, Shin Kong Life is sufficiently large in Taiwan’s life insurance market. Its fourth-place ranking by 2024 total premiums, total premium market share of 7.8%, more than 7,300 agents, 8.99 million in-force policies, and 2025 new business CSM of NT$64.9bn show that it is not a small insurer. Under TS Holdings, it also has greater scope to use bancassurance, securities, asset management, digital capabilities, and the group customer base.

However, the constraints from capital and investment earnings are substantial. The post-hedging investment return fell to 2.57% in 2025, while the liability cost was 3.71%. The former Shin Kong Life’s end-2025 capital adequacy ratio did not meet the statutory requirement. Overseas fixed-income assets accounted for 66.4% of total investments, and the company depends on foreign-currency assets and hedging, Taiwan dollar appreciation, and the foreign currency price fluctuation reserve. Compared with higher-rated Taiwanese life insurers with relatively thicker capital buffers, this is a constraint on ratings and spreads.

By security class, issuer credit and Tier 2 should be separated. The post-merger Shin Kong Life may have support capacity as a core insurance subsidiary under TS Holdings. However, the USD Tier 2 is a subordinated guarantee even though it carries an issuer guarantee, and it ranks below policyholders and senior creditors. The rating configuration of Fitch IDR BBB-, IFS BBB, S&P BBB+, and the USD Tier 2 expected S&P rating of BBB shows the differences among issuer credit, insurer financial strength, and security ranking.

No investment view to buy, hold, sell, or avoid is given for relative value, because market price, spread, yield, OAS, and comparisons with same-tenor Taiwanese financial institution Tier 2, similarly rated insurance subordinated bonds, and Cathay/Nan Shan foreign-currency subordinated bonds have not been confirmed. Without market data, what can be said is that Shin Kong Life’s USD Tier 2 should not be treated simply as a “large Taiwanese life insurer” premium instrument. It is a security that should require a risk premium reflecting pending confirmation of post-merger capital improvement, former-company capital non-compliance, Taiwan dollar appreciation, hedging cost, regulatory capital characteristics, and the subordinated guarantee ranking.

Compared with domestic financial institutions, the credit differs in nature from deposit-led bank credits such as Taishin Bank or large Taiwanese banks. Banks are analysed through loan assets, deposits, capital ratios, liquidity ratios, and non-performing loans, while Shin Kong Life should be analysed through insurance contract liabilities, CSM, foreign-currency assets, hedging, TIS/RBC, claims, surrenders, and ALM. The difference in risk behaviour should be reflected, not merely the rating symbol.

9. Key Credit Strengths and Constraints

Shin Kong Life’s first credit strength is its large franchise in Taiwan’s life insurance market. Established in 1963, with a 2024 total premium market share of 7.8%, fourth-place ranking by total premiums, more than 7,300 sales agents, 3.93 million insured persons, 8.99 million in-force policies, a 13-month persistency ratio of 96.7%, and a 25-month persistency ratio of 93.7%, the company has an established policyholder base and distribution network.

The second strength is the benefit of integration under TS Holdings. The combination of Taishin’s banking, securities, and asset management functions with Shin Kong’s life insurance platform provides scope to improve channel diversification, cross-selling, product design, capital raising, and group risk management. The increase in 2025 new business CSM to NT$64.9bn and the rise in CSM/FYP to 109.5% are also signs of a move toward a more value-focused product mix.

The third strength is capital market access. The former Shin Kong Life reinforced capital through domestic subordinated debt and capital increases in 2023-2024, and issued USD400mn of Tier 2 in the international market in June 2025. The ability to raise capital is important for an insurer’s stress resilience. In particular, for an insurer with a history of capital deficiency, credit quality depends on whether it can restore capital through coordination with the parent, markets, and regulators.

The largest constraint, however, is capital. The company was classified as capital deficient in 2023, recovered in 2024, but the former Shin Kong Life’s end-2025 capital adequacy ratio did not meet the statutory requirement. Post-merger platform RBC/TIS presentations show improvement, but to confirm that the former company’s weakness has completely disappeared, investors need to review the 2026 post-merger financial statements, TIS, capital sensitivities, and parent capital policy. The company should be viewed not as a strongly capitalised insurer, but as an insurer under capital reconstruction.

The second constraint is FX, ALM, and investment earnings. In 2025, 66.4% of investment assets were overseas fixed income, and the regional distribution of overseas fixed income was 42.4% North America, 23.2% Europe, and 34.4% Asia Pacific and others. The post-hedging investment return fell to 2.57% in 2025, below the liability cost of 3.71%. Hedging cost rose to 2.17%. Taiwan dollar appreciation, US dollar interest rates, overseas credit spreads, hedging cost, and the foreign currency price fluctuation reserve materially affect earnings and capital.

The third constraint is integration execution risk. The January 2026 merger of the life insurance companies involves legal succession, IT, sales, products, agents, bancassurance, risk management, accounting, fair value assessment, and regulatory capital integration. Integration may improve the company profile, but in the short term PPA, reserves, accounting standards, capital standards, system integration, and differences in sales culture may affect earnings and capital. Fitch maintained Rating Watch Evolving because this uncertainty had not yet been resolved.

The fourth constraint is security risk on subordinated debt. The USD Tier 2 carries an issuer guarantee, but under the Offering Circular the guarantee is a subordinated guarantee from the former Shin Kong Life and ranks below Senior Creditors in liquidation. There are regulatory capital events, tax events, merger events, guarantor substitution, redemption restrictions, and regulatory approval requirements, and the security should not be treated in the same way as senior debt. Investment analysis must explicitly incorporate higher security risk than issuer credit, or lower security ranking and rating than issuer credit.

10. Downside Scenarios and Monitoring Triggers

The most realistic downside scenario for Shin Kong Life is renewed capital pressure from Taiwan dollar appreciation and rising hedging costs. Because overseas fixed-income assets account for 66.4% of total investments, a rapid appreciation of the Taiwan dollar could simultaneously worsen valuation losses on unhedged foreign-currency assets, hedging costs, the foreign currency price fluctuation reserve, comprehensive income, TIS/RBC, and rating agency capital models. The former Shin Kong Life’s end-2025 capital adequacy non-compliance showed that this path can actually feed into credit metrics.

The second downside is a scenario in which the post-merger capital buffer is thinner than expected. TS Holdings’ materials show the post-merger TIS ratio on 1 January 2026 at above 125%, but this only indicates a level above the minimum and does not sufficiently show stress headroom or sensitivities. The extent to which the former Shin Kong Life’s capital deficiency remains after integration, and how far it is absorbed by Taishin Life-side capital or group capital, should be confirmed in the 2026 financials. The level of foreign-currency, interest-rate, equity, and insurance risk the post-merger company can take needs ongoing monitoring.

The third downside is a prolonged period in which investment returns do not sufficiently exceed the liability cost. The combination in 2025 of a post-hedging investment return of 2.57%, pre-hedging recurring yield of 3.37%, and liability cost of 3.71% indicates thin spread headroom. Rising rates may be positive for reinvestment yields, but if they are accompanied by valuation losses on existing bonds, hedge collateral needs, rising surrenders, and lower capital, the net effect is negative. Falling rates may generate valuation gains, but may also compress the spread between reinvestment yield and guaranteed rates. The key issue is not the direction of rates itself, but the duration and currency mismatch between assets and liabilities.

The fourth downside is a scenario in which product mix improvement does not translate into realised profits. The 2025 increase in new business CSM is positive, but profitability of protection, health, and group insurance depends on claims, medical inflation, rate revisions, reinsurance, and persistency. Foreign-currency insurance may contribute to ALM improvement, but policyholder explanation, FX volatility, regulatory tightening, and sales quality issues may arise. CSM is an indicator of future profits, not immediately available cash or regulatory capital itself.

The fifth downside is deterioration in ratings, market access, and Tier 2 valuation. If Fitch’s Rating Watch Evolving is resolved negatively, S&P’s Negative outlook results in a downgrade, TS Holdings group ratings decline, or liquidity in the USD Tier 2 deteriorates, refinancing costs and market valuation would worsen. For Tier 2, even if issuer credit is maintained, investor returns may change materially because of non-call, interest payment restrictions, regulatory approval, changes in capital recognition, or guarantor substitution.

Monitoring items are post-merger TIS/RBC and the net worth ratio, USD/TWD and hedging costs, the foreign currency price fluctuation reserve, post-hedging investment return, liability cost, CSM/FYP, claims and surrenders, integration costs, the resolution direction of Fitch RWE and S&P Negative, and succession, redemption, and regulatory events for the USD Tier 2. Deterioration signals include a shrinking TIS buffer, additional recognition of losses inherited from the former SKL, rapid Taiwan dollar appreciation, continued yields below liability cost, declining CSM, worsening surrenders or claims, downgrades, and reduced transparency over guarantor changes. Improvement signals include clearer TIS headroom, recovery in post-hedging yield, sustained high CSM, stable claims, stabilisation of rating outlooks, and clearer Tier 2 succession and capital treatment.

11. Credit View and Monitoring Focus

At present, Shin Kong Life is a transition-period life insurance credit with a large incumbent franchise in Taiwan’s life insurance market, but with clear standalone vulnerability in capital and FX/ALM from the former company. The direction of credit quality has room to improve, but the former Shin Kong Life’s end-2025 capital adequacy non-compliance and Fitch’s Rating Watch Evolving mean improvement cannot be regarded as complete. The probability of rapid change in credit quality level or direction is moderate, because FX, TIS/RBC, post-merger fair value assessment, rating actions, and Tier 2 terms could change the view over a short period.

The credit strengths are the company’s fourth-place franchise in Taiwan by 2024 total premiums, more than 7,300 sales agents, 8.99 million in-force policies, high persistency, the 2025 increase in new business CSM, the banking, securities, and asset management platform of the TS Holdings group, and a record of capital raising in domestic and overseas markets. The constraints are the former company’s history of capital deficiency and FX/ALM risk. The sequence of capital deficiency in 2023, recovery through capital reinforcement in 2024, and renewed statutory capital adequacy non-compliance at the former Shin Kong Life at end-2025 shows that the company’s capital is sensitive to markets, FX, and regulatory calculations.

By security class, senior issuer credit and Tier 2 should be separated. Under the Offering Circular, the USD Tier 2 carries a subordinated guarantee from the former Shin Kong Life and is subordinated to policyholders and senior creditors. Post-merger guarantor succession / substitution procedures are unconfirmed, and the call, interest payment, regulatory capital event, guarantor substitution, and post-merger succession provisions should be checked before investing in the individual bond.

The monitoring focus going forward is the 2026 post-merger financials, TIS/RBC, fair value adjustments inherited from the former Shin Kong Life, the foreign currency price fluctuation reserve, post-hedging investment return, liability cost, CSM, claims, surrenders, Fitch RWE, S&P Negative outlook, and USD Tier 2 succession and terms. No relative value judgment is made because market spreads have not been confirmed, but the credit view would be more likely to improve if TIS headroom, resolution of the rating Watch, recovery in post-hedging yield, and steady profit release from CSM are confirmed.

12. Short Summary & Conclusion

Shin Kong Life Insurance is a leading Taiwanese life insurer with a large policyholder base and distribution network. In January 2026, it merged with Taishin Life and became the core life insurance platform under TS Holdings. Credit quality is supported by the franchise, CSM improvement, and group integration benefits, while the main constraints are the former Shin Kong Life’s end-2025 capital adequacy non-compliance, foreign-currency investments, hedging costs, insurance liabilities, and Tier 2 subordination. Cautious ongoing monitoring is required until TIS/RBC, FX/ALM, resolution of rating Watch, and the post-merger guarantor succession and terms for the USD Tier 2 are confirmed from 2026 onward.

13. Sources

Primary Company Sources

• TS Financial Holding Co., Ltd., 4Q25 Quick Fact, accessed 2026-05-15.
  https://www.tsholdings.com.tw/tsh/relations/files/4Q25_Quick-Fact_ENG.pdf
• TS Financial Holding Co., Ltd., 4Q25 Analyst Meeting Presentation, 2026-03-31, accessed 2026-05-15.
  https://www.tsholdings.com.tw/tsh/relations/files/4Q25_TS-Holdings_Analyst-meeting_CHI.pdf
• TS Financial Holding Co., Ltd. and subsidiaries, Consolidated Financial Statements for the year ended December 31, 2025, accessed 2026-05-15.
  https://www.tsholdings.com.tw/tsh/relations/files/2025-4Q-consolidated-financial-statements_e.pdf
• TS Holdings, 4Q25 analyst meeting press release, 2026-03-31, accessed 2026-05-15.
  https://www.tsholdings.com.tw/tsh/news/latest/1774952820000/?__locale=en
• TS Holdings, About TS Holdings / member profile pages, accessed 2026-05-15.
  https://www.tsholdings.com.tw/tsh/about/overview/?__locale=en
https://www.tsholdings.com.tw/tsh/about/member/?__locale=en
• Shin Kong Life Insurance, 2024 Sustainability Report, accessed 2026-05-15.
  https://esg.skl.com.tw/uploads/report/2024SKL_SustainabilityReport_EN_SSK.pdf
• Shin Kong Life Singapore Pte. Ltd., U.S.$400,000,000 6.95 per cent. Tier 2 Subordinated Dated Capital Bonds due 2035 offering circular, 2025-06-26, accessed 2026-05-15.
  https://links.sgx.com/FileOpen/Shin%20Kong%20Life%20Singapore%20Pte.%20Ltd.%20-%20Final%20Offering%20Circular.ashx?App=Prospectus&FileID=66489

Rating Agency And Market Data Sources

• Fitch Ratings, Fitch Maintains Rating Watch Evolving on Shin Kong Life, 2025-11-14, re-published by TradingView / Reuters, accessed 2026-05-15.
  https://www.tradingview.com/news/reuters.com%2C2025-11-14%3Anewsml_FIT6fxSHX%3A0-fitch-maintains-rating-watch-evolving-on-shin-kong-life/
• Taiwan Ratings, Shin Kong Life Insurance Co. Ltd. profile, accessed 2026-05-15.
  https://www.taiwanratings.com/portal/front/memberProfile?ratingId=5685
• Cbonds, S&P Global Ratings assigns BBB+ foreign-currency long-term credit rating to Shin Kong Life Insurance, 2025-06-13, accessed 2026-05-15.
  https://cbonds.com/news/3444615/

Internal Working Data

• issuer_summary/issuers/shin_kong_life_insurance/data/shin_kong_life_insurance_key_metrics_20260515.json
• issuer_summary/issuers/shin_kong_life_insurance/working/shin_kong_life_insurance_20260515_writing_plan.md

Unverified / Pending

• Shin Kong Life’s official 1Q26 post-merger financials, details of post-merger TIS, and stress sensitivities as of 1 January 2026 are unconfirmed.
• The former Shin Kong Life’s end-2025 capital adequacy ratio was confirmed as “below the statutory requirement,” but the exact RBC ratio could not be confirmed in TS Holdings’ English consolidated financial statements.
• The Taishin Life -> Shin Kong Life RBC of 421% and TIS above 125% in TS Holdings’ 4Q25 materials are treated as indicators for the legal surviving entity / post-merger company, and are not the same perimeter as the former Shin Kong Life’s standalone end-2025 RBC.
• The full text of S&P Global Ratings’ June 2025 detailed report has not been obtained. Only the rating level was confirmed from Cbonds and TS Holdings materials.
• Fitch’s 14 November 2025 release was confirmed through TradingView / Reuters republication rather than the official Fitch page.
• The full text of Taiwan Ratings’ 31 December 2025 post-merger rating withdrawal release has not been obtained. Only the rating history and issuer page on the profile were confirmed.
• The full Trust Deed for the USD Tier 2, execution status of the Substituted Obligor after the merger, practical completion of guarantor change, and details of interest suspension, redemption restrictions, and loss absorption provisions are unconfirmed.
• Product-level margins, product-level CSM, claims ratios, rate revision capacity for medical and accident products, surrender rates, guaranteed rates, ALM gap, detailed breakdown of hedging costs, and reinsurance programme are unconfirmed.
• Investment asset maturity ladder, surrender stress, hedge collateral and liquidity needs, and haircuts on liquid assets available for sale under stress are unconfirmed.
• Market price, spread, yield, OAS, relative value versus peers and similarly rated bonds, and market assessment of call probability are unconfirmed. This report does not make a buy, sell, or hold recommendation based on market levels.